USE OF DATA OF EVIDENCE BASED MEDICINE IN CLINICAL PRACTICE
https://doi.org/10.51523/2708-6011.2008-5-3-7
Abstract
The purpose of article is the review of principles of evidence based medicine in surgery. A prominent aspect of evidence based medicine in surgery is definition of degree of reliability of the information.
About the Authors
A. A. Litvin
Gomel Regional Clinical Hospital
Belarus
Belarus
A. L. Kalinin
Gomel State Medical University
Belarus
Belarus
N. M. Trizna
Gomel State Medical University
Belarus
Belarus
References
1. Systematic reviews and meta-analysis for the surgeon scientist / S. S. Mahid [et al.] // Br. J. Surg. - 2006. - Vol. 93. - P. 1315-1324.
2. Гринхальх, Т. Основы доказательной медицины / Т. Гринхальх; пер. с англ. - М.: ГЭОТАР-Медиа, 2006. - 240 с.
3. Флетчер, Р. Клиническая эпидемиология. Основы доказательной медицины / Р. Флетчер, С. Флетчер, Э. Вагнер; пер. с англ. - М.: Медиа Сфера, 1998. - 352 с.
4. Базылев, В. В. Статистическая обработка данных в систематических обзорах по хирургии / В. В. Базылев, Ю. В. Белов // Хирургия. - 2008. - № 4. - С. 48-54.
5. Власов, В. В. Введение в доказательную медицину / В. В. Власов. - М.: Медиа Сфера, 2001. - 392 с.
6. Intravenous immunoglobulin for treating sepsis and septic shock / M. Alejandria [et al.] // Cochrane Database Syst. Rev. (2): CD001090.
7. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock / D. Annane [et al.] // JAMA. - 2002. - Vol. 288. - P. 862-871.
8. Early goal-directed therapy in the treatment severe sepsis and septic shock / E. Rivers [et al.] // N. Engl. J. Med. - 2001. - Vol. 345. - P. 1368-1377.
9. The recombinant human activated protein C worldwide evaluation in severe sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis / G. Bernhard [et al.] // N. Engl. J. Med. - 2001. - Vol. 344. - P. 699-709.
10. Davidson, B. Low-dose heparin for severe sepsis / B. Davidson, W. Geerts, A. Lensing // N. Engl. J. Med. - 2002. - Vol. 347. - P. 1036-1037.
11. Методология клинических исследований в хирургии / О. Г. Скипенко [и др.] // Хирургия. - 2008. - № 1. - С. 36-42.
12. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation / F. Fourrier [et al.] // Chest. - 1993. - Vol. 104. - P. 882-888.
13. High -dose antithrombine III in severe sepsis. A randomized controlled trial / B. Warren [et al.] // JAMA. - 2001. - Vol. 286. - P. 1869-1878.
14. Antithrombine III in patients with severe sepsis / B. Eisel [et al.] // Intensive Care Med. - 1998. - Vol. 24. - P. 663-672.
15. Infusion of methylene blue in human septic shock: randomaized, controlled study / M. Kirov [et al.] // Crit. Care Med. - 2001. - Vol. 29. - P. 1860-1867.
16. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature / L. Cronin [et al.] // Crit. Care Med. - 1995. - Vol. 23. - P. 1430-1439.
17. Molnar, Z. N-acetylcysteine treatment to prevent the progression of MOF: prospective, randomized, placebo-controlled study / Z. Molnar, E. Shearer, D. Lowe // Crit. Care Med. - 1999. - Vol. 27. - P. 1100-1104.
18. Nathens, A. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients / A. Nathens, M. Neff, G. Jurcovich // Ann. Surg. - 2002. - Vol. 236. - P. 814-822.
19. Юрьев, К. Л. Доказательная медицина. Кокрановское сотрудничество / К. Л. Юрьев, К. Н. Логановский // Укр. мед. часопис. - 2000. - № 6. - С. 20-25.
20. EBIC-guidelines for management of severe head injury in adults. European Brain Injury Consortium / A. Maas [et al.] // Acta Neurochir. Wien. - 1997. - Vol. 139. - P. 286-294.
21. Perez, J. Other supportive therapies in sepsis / J. Perez, R. P. Dellinger // Intensive Care Med. - 2001. - Vol. 27. - P. 116-127.
22. Surviving Sepsis Campaing guidelines for management of severe sepsis and septic shock / R. P. Dellinger [et al.] // Crit. Care Med. - 2004. - Vol. 32. - P. 858-873.
23. Guidelines for the management of acute pancreatitis / J. Toouli [et al.] // J. Gastroenterol. Hepatol. - 2002. - Vol. 17 (Suppl.). - Р. 15-23.
24. JPN Guidelines for the management of acute pancreatitis: cutting-edge information / T. Takada [et al.] // J. Hepatobiliary Pancreat. Surg. - 2006. - Vol. 13. - P. 2-6.
25. Царенко, С. В. Доказательная медицина и критические состояния / С. В. Царенко, Г. К. Болякина // Вестн. инт. терапии - 2003. - № 1. - С. 79-82.
26. Potential benefits, limitations, and harms of clinical guidelines / S. H. Woolf [et al.] // BMJ. - 1999. - Vol. 318. - P. 527-530.
27. Ledingham, I. M. Evidence based medicine: physicians' perceptions / I. M. Ledingham // Intensive Care Med. - 2001. - Vol. 27. - P. 467-466.
28. Evidence-based treatment of acute pancreatitis. A look at established paradigms / S. Heinrich [et al.] // Ann. Surg. - 2006. - Vol. 243. - Р. 154-168.
29. UK guidelines for management of acute pancreatitis: is it time to change? / K. S. Gurusamy [et al.] // Gut. - 2005. - Vol. 54. - P. 1344-1345.
30. Зильбер, А. П. Научно-доказательная медицина: реальная польза или исследовательская мода? Актуальные проблемы медицины критических состояний. - Петрозаводск: Изд-во ПетрГУ, 2001. - Вып. 8. - 123 c.
Review
For citations:
Litvin A.A., Kalinin A.L., Trizna N.M. USE OF DATA OF EVIDENCE BASED MEDICINE IN CLINICAL PRACTICE. Health and Ecology Issues. 2008;(3):36-41. (In Russ.) https://doi.org/10.51523/2708-6011.2008-5-3-7
Views: 241
Email this article 